Open AccessTargeting ALK for cancer therapy: high throughput screening assays
Author(s) -
Mohamad Fairus Abdul Kadir,
Pratheev Alagapan,
Yang Jin Lim,
Wai Mun Kong,
Dharvind Balan,
Mathura Subangari Dorasamy,
Wesley Roy Balasubramanian,
Sivapriya Marappan,
Umarani Subramaniam,
Kavitha Nellore,
Thomas Anthony
Publication year - 2018
Publication title -
frontiers in pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.384
H-Index - 86
ISSN - 1663-9812
DOI - 10.3389/conf.fphar.2018.63.00017
Subject(s) - crizotinib , anaplastic lymphoma kinase , alectinib , ceritinib , drug discovery , alk inhibitor , targeted therapy , cancer research , companion diagnostic , cancer , high throughput screening , medicine , biology , bioinformatics , lung cancer , oncology , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom